57 results on '"de Ferranti, Sarah"'
Search Results
2. Adherence to lipid-lowering therapy and reaching treatment goals in youth seen in a preventive cardiology clinic
3. Lack of Age-Appropriate Reference Intervals Causing Potentially Missed Alerts in Clinical Reports of Dyslipidemia
4. Dyslipidemia Among Adults With Congenital Heart Disease
5. Association of Acute Anti-inflammatory Treatment With Medium-term Outcomes for Coronary Artery Aneurysms in Kawasaki Disease
6. Age, Sex, Race/Ethnicity, and Income Patterns in Ideal Cardiovascular Health Among Adolescents and Adults in the U.S.
7. Variation in Pharmacologic Management of Patients with Kawasaki Disease with Coronary Artery Aneurysms
8. Infliximab versus second intravenous immunoglobulin for treatment of resistant Kawasaki disease in the USA (KIDCARE): a randomised, multicentre comparative effectiveness trial
9. Helping young women go red: Harnessing the power of personal and digital information to prevent heart disease
10. B-PO02-041 ACTIVITY DURING THE COVID-19 PANDEMIC IN CHILDREN WITH CARDIAC RHYTHM MANAGEMENT DEVICES
11. Detailed Assessment of Left Ventricular Function in Multisystem Inflammatory Syndrome in Children, Using Strain Analysis
12. Improving Cardiovascular Health in a Pediatric Preventive Cardiology Practice
13. CARDIOVASCULAR HEALTH CHARACTERISTICS IN CHILDREN AND ADOLESCENTS WITH CONGENITAL HEART DISEASE
14. Multiple Emergency Department Visits for a Diagnosis of Kawasaki Disease: An Examination of Risk Factors and Outcomes
15. Children with Heterozygous Familial Hypercholesterolemia in the United States: Data from the Cascade Screening for Awareness and Detection-FH Registry
16. Cardiovascular health decline in adolescent girls in the NGHS cohort, 1987–1997
17. Young Women's Perceptions of Heart Disease Risk
18. Low-Molecular-Weight Heparin vs Warfarin for Thromboprophylaxis in Children With Coronary Artery Aneurysms After Kawasaki Disease: A Pragmatic Registry Trial
19. Update on Preventive Cardiology
20. Pediatric Lipid Screening and Treatment in Canada: Practices, Attitudes, and Barriers
21. Cardiovascular Risk and Cardiovascular Health Behaviours in the Transition From Childhood to Adulthood
22. Missed or delayed diagnosis of Kawasaki disease during the 2019 novel coronavirus disease (COVID-19) pandemic
23. Anti-thrombosis management of patients with Kawasaki disease: Results from an international survey
24. Practice of lipoprotein apheresis and short-term efficacy in children with homozygous familial hypercholesterolemia: Data from an international registry
25. Type 1 diabetes is associated with an increase in cholesterol absorption markers but a decrease in cholesterol synthesis markers in a young adult population
26. Impact of Socioeconomic Status on Outcomes of Patients with Kawasaki Disease
27. Associations of Blood Pressure and Cholesterol Levels During Young Adulthood With Later Cardiovascular Events
28. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol: Executive Summary
29. 2018 AHA/ACC/AACVPR/AAPA/ABC/ACPM/ADA/AGS/APhA/ASPC/NLA/PCNA Guideline on the Management of Blood Cholesterol
30. Homozygous Familial Hypercholesterolemia in the United States: Data from the CASCADE-FH Registry†
31. Familial Hypercholesterolemia Among Young Adults With Myocardial Infarction
32. Clinical Genetic Testing for Familial Hypercholesterolemia
33. Awareness of Cardiovascular Risk Factors in U.S. Young Adults Aged 18–39 Years
34. QUALITY IMPROVEMENT IN OUTPATIENT PEDIATRIC CARDIOLOGY: EARLY EXPERIENCE WITH THE AMERICAN COLLEGE OF CARDIOLOGY, QUALITY NETWORK
35. Safety and Efficacy of Warfarin Therapy in Kawasaki Disease
36. Cholesterol Screening and Treatment Practices and Preferences: A Survey of United States Pediatricians
37. Statin-Associated Myopathy in a Pediatric Preventive Cardiology Practice
38. Pediatric Familial Hypercholesterolemia: Children and Adolescents Enrolled in the CAscade SCreening for Awareness
39. Kawasaki disease and immunisation: A systematic review
40. Transitioning from pediatric to adult health care with familial hypercholesterolemia: Listening to young adult and parent voices
41. Kawasaki disease and immunisation: Standardised case definition & guidelines for data collection, analysis
42. Correlates of Achieving Statin Therapy Goals in Children and Adolescents with Dyslipidemia
43. Nutrition in Children and Adolescents
44. Adolescent Dyslipidemia and Standardized Lifestyle Modification
45. Adolescent Perceptions of Cholesterol Screening Results: “Young Invincibles” or Developing Adults?
46. Coronary Artery Aneurysm Measurement and Z Score Variability in Kawasaki Disease
47. Familial hypercholesterolemia in children and adolescents: A clinical perspective
48. Treatment decision making for adolescents with familial hypercholesterolemia: Role of family history and past experiences
49. Vascular Health in Kawasaki Disease
50. Childhood Cholesterol Disorders: The Iceberg Base or Nondisease?
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.